News

4th Annual G-FINDER Survey Released

Click here for full report.

Today, the fourth annual G-FINDER survey tracking funding for research and development of neglected disease technologies was released. This year’s report shows that funding for product development is on the decline and product development partnerships (PDPs) have been particularly hard hit, as eight of the top twelve public donors cut their funding in 2010.

While the report shows that funding for TB R&D increased by $30M from 2009 – 2010, annual funding is still barely 25% of the figure suggested by the Stop TB Partnership as adequate to sustain the pace of R&D to bring critically-needed new TB products to the field without delay. Investments by public and philanthropic donors over the past 10 years have built a pipeline of products that will transform TB control. Turning away from these projects means that we will continue to wage the fight against TB with inadequate tools. Now is a time of tremendous opportunity, with dozens of potential products within the reach of patients–donors must commit to taking them across the finish line.

Read full report.

Read report highlights.

For those who use Twitter, here are some prepared tweets to highlight the urgent need to maintain funding for TB R&D. To use them:

  1. Sign into twitter
  2. Click any of the links below, which will automatically load
  3. Press “tweet”

Tweet #1

#PDP funding decreased for a 2nd straight year, putting 100+ global health projects in jeopardy. #RnD4NTDs #GFINDER http://bit.ly/rCw3QL

Click here to automatically load.

Tweet #2

A decade of work built a robust pipeline of new TB drugs. We must see them across the finish line. #RnD4NTDs #GFINDER http://bit.ly/rCw3QL

Click here to automatically load.

Tweet #3

#TB doesn’t heed a global financial crisis. Global health funding cuts only embolden pandemics. #RnD4NTDs #GFINDER http://bit.ly/rCw3QL

Click here to automatically load.

More News
23 Aug 2022
Last week, the PAN-TB collaboration announced initial plans for a Phase 2 clinical trial evaluating two novel drug regimens to treat Tuberculosis. Sponsored by the Bill and Melinda Gates Foundation, the PAN-TB, or “Project to Accelerate New Treatments for Tuberculosis”, collaboration brings...
4 May 2022
Earlier this week, the World Health Organization (WHO) released a rapid communication which detailed the upcoming changes to the treatment guidance for drug-resistant tuberculosis (DR-TB). These guidelines are used to inform national TB programmes globally on how to treat patients with these...
5 Apr 2022
On April 01, 2022, the Stop TB Partnership launched the second online consultation for the new Global Plan to End TB 2023-2030. Over the years, the Global Plans have been important tools for advocacy and resource mobilization, and served as a reference document for donors and stakeholders. In May...